CareFusion Co. (NYSE: CFN) updated its FY13 earnings guidance on Thursday. The company provided EPS guidance of $2.11-2.21 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.15, Analyst Ratings Network.com reports. The company issued revenue guidance of flat to down LSD, compared to the consensus revenue estimate of $3.66 billion.

Several analysts have also recently commented on the stock. Analysts at BMO Capital Markets reiterated an outperform rating on shares of CareFusion in a research note to investors on Friday, May 3rd. They now have a $38.00 price target on the stock. On a related note, analysts at Deutsche Bank raised their price target on shares of CareFusion from $34.00 to $35.00 in a research note to investors on Friday, April 12th. They now have a hold rating on the stock. Finally, analysts at Raymond James raised their price target on shares of CareFusion from $38.00 to $42.00 in a research note to investors on Monday, March 25th. They now have a strong-buy rating on the stock.

Four research analysts have rated the stock with a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company. CareFusion presently has an average rating of Buy and a consensus target price of $34.64.

CareFusion Co. (NYSE: CFN) traded up 0.09% on Thursday, hitting $34.65. CareFusion Co. has a 1-year low of $23.77 and a 1-year high of $35.61. The stock’s 50-day moving average is currently $34.42. The company has a market cap of $7.713 billion and a price-to-earnings ratio of 24.23.

CareFusion (NYSE: CFN) last released its earnings data on Thursday, May 9th. The company reported $0.59 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.53 by $0.06. The company had revenue of $901.00 million for the quarter, compared to the consensus estimate of $908.12 million. CareFusion’s revenue was down 2.0% compared to the same quarter last year. CareFusion has set its FY13 guidance at $2.11-2.21 EPS. On average, analysts predict that CareFusion Co. will post $2.15 earnings per share for the current fiscal year.

CareFusion Corporation (NYSE: CFN) is a global medical technology company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.